Drug manufacturer Sanofi drew attention this month when it added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.
Pfizer and Amgen also recently added similar 45-day lookback requirements to their restrictions on 340B contract pharmacy arrangements. A senior pharmacist at a 340B hospital pointed out this week that GlaxoSmithKline (GSK), Johnson & Johnson (J&J), and Lilly’s contract pharmacy policies already had comparable language.
Covered entities are concerned about 45-day lookback requirements that at least least six drug manufacturers have included in or added to their restrictions on 340B contract pharmacy arrangements.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
